The bulk of BPC-157 research has focused on tissue repair (tendon, muscle, ligament, bone), gastrointestinal protection (ulcer models, IBD models, gut-brain axis), wound healing acceleration, and neuroprotection
Decrease in mitochondrial complex i activity in ischemic/reperfused rat heart - involvement of reactive oxygen species and cardiolipin
Recalls & Warnings August 23, 2013 FDA Warns Consumers of Supplement Containing Prescription Anti-Inflammatory Drug On August 22, 2013, the FDA warned consumers not to use or purchase the dietary supplement Ortiga, because it contains the prescription drug ingredient, diclofenac
BPC-157 is being investigated for its potential to accelerate tissue repair, ease chronic inflammation, and enhance recovery in both musculoskeletal and gut-related conditions